The notices it replaced
- Reissues: PAR-21-306 NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
Replaced by PAR-28-063.
Who won it before
55 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,852,418 in first-year total cost, median $166,984.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-5 (M1)]17
- Special Emphasis Panel[ZCA1 RTRB-Y (O1)]13
- Special Emphasis Panel[ZCA1 SRB-1 (M1)]8
- Special Emphasis Panel[ZCA1 SRB-1 (O1)]6
- Special Emphasis Panel[ZCA1 RPRB-6 (J2)]4
Most frequent institutions
- UNIVERSITY OF KANSAS MEDICAL CENTER4
- EMORY UNIVERSITY3
- JOHNS HOPKINS UNIVERSITY3
- UNIVERSITY OF PENNSYLVANIA3
- BAYLOR COLLEGE OF MEDICINE2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Advancing Treatment for Head and Neck Cancer Patients with Competing Health Risks through Multi-Center Randomized Trials1R50CA305194-01 | MELL, LOREN K. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $988,224 | ZCA1 |
| 2025 | Efforts to Discover Novel Therapies and Reduce Treatment Toxicities for Lymphoma and Chronic Lymphocytic Leukemia Patients Through Collaboration and the NCTN1R50CA305062-01 | HU, BOYU | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH, UT | $935,075 | ZCA1 |
| 2025 | NCI Research Specialist (Clinician Scientist) Award1R50CA305109-01 | SCHAFER, ERIC STEPHEN | BAYLOR COLLEGE OF MEDICINE, TX | $882,470 | ZCA1 |
| 2025 | Enhancing NCI-funded research at the University of Arizona Cancer Center1R50CA288381-01A1 | SHROFF, RACHNA | UNIVERSITY OF ARIZONA, AZ | $575,051 | ZCA1 |
| 2025 | Advancing Cancer Screening and Prevention Trials at the University of Colorado Cancer Center1R50CA305205-01 | WOOD, MARIE E. | UNIVERSITY OF COLORADO DENVER, CO | $547,080 | ZCA1 |
| 2025 | Promoting Lead Academic Participating Sites (LAPS) Studies Accrual and Lung cancer Screening in Oklahoma1R50CA305191-01 | ALJUMAILY, RAID | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $424,480 | ZCA1 |
| 2025 | Proposal for NCI Research Specialist (Clinician Scientist) Award1R50CA305013-01 | MISHRA, MARK V. | UNIVERSITY OF MARYLAND BALTIMORE, MD | $375,025 | ZCA1 |
| 2025 | NCI Research Specialist (Clinician Scientist) Award for Improving Cancer Screening and Clinical Trial Enrollment1R50CA292022-01A1 | STRATTON, KELLY LYNN | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $361,695 | ZCA1 |
| 2025 | Instituting NCI-funded thyroid and head and neck cancer studies1R50CA305244-01 | SHERMAN, ERIC | SLOAN-KETTERING INST CAN RESEARCH, NY | $201,870 | ZCA1 |
| 2025 | Rare Tumor Clinical Research Specialist1R50CA305079-01 | LAETSCH, THEODORE WILLIS | CHILDREN'S HOSP OF PHILADELPHIA, PA | $197,518 | ZCA1 |
| 2025 | Clinical Trials Specialist in NCI Clinical Trials Research1R50CA288588-01A1 | LASSMAN, ANDREW B | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $193,926 | ZCA1 |
| 2025 | Engaging Impactful Immunotherapy Approaches in Renal Cell Cancer Studies1R50CA288482-01A1 | HAAS, NAOMI B | UNIVERSITY OF PENNSYLVANIA, PA | $178,893 | ZCA1 |
| 2025 | Enhancing access in breast cancer prevention clinical trials1R50CA305048-01 | NYE, LAUREN ELIZABETH | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $135,951 | ZCA1 |
| 2025 | Expanding access and enrollment to precision medicine trials in Acute Myeloid Leukemia1R50CA293244-01A1 | LIN, TARA | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $135,949 | ZCA1 |
| 2025 | A System to Support Development and Success of NCI-Sponsored Trials for Rare Diseases1R50CA305057-01 | REISS BINDER, KIM A | UNIVERSITY OF PENNSYLVANIA, PA | $122,610 | ZCA1 |
| 2025 | Expanding access to perioperative and repurposed drug trials in melanoma and other solid tumors1R50CA292121-01A1 | LOWE, MICHAEL | EMORY UNIVERSITY, GA | $83,925 | ZCA1 |
| 2025 | Expansion of NCI-sponsored clinical research in hematologic malignancies to Brooklyn and Queens1R50CA305218-01 | MARTIN, PETER | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $1 | ZCA1 |
| 2024 | Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center1R50CA285409-01A1 · under PAR-21-306 | HERRERA, ALEX F. | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $208,103 | ZCA1 |
| 2024 | Advancing novel cancer preventive and therapeutic strategies across the modern NCI clinical trial networks1R50CA285412-01 · under PAR-21-306 | ZELL, JASON | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $196,267 | ZCA1 |
| 2024 | Optimization of strategies to improve NCI-sponsored clinical trial participation throughout the Weill Cornell Medicine - Meyer Cancer Center Sphere1R50CA285498-01A1 · under PAR-21-306 | TAGAWA, SCOTT T | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $194,778 | ZCA1 |
| 2024 | Multi-omic liquid biopsy assessment in NCI trials: evaluating ctDNA, extravesicle RNA, and outcomes with immunotherapy in patient with colorectal and anal cancers1R50CA285403-01A1 · under PAR-21-306 | MORRIS, VAN K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $181,640 | ZCA1 |
| 2024 | Advancing novel therapeutics and translational science to close the survivorship gap in pediatric, adolescent and young adult (AYA) lymphoma1R50CA285492-01 · under PAR-21-306 | CASTELLINO, SHARON MARIE | EMORY UNIVERSITY, GA | $178,909 | ZCA1 |
| 2024 | Developing, Implementing and Supporting NCI Clinical Trials and the National Cancer Trials Network (NCTN) in Breast Cancer and Developmental Therapeutics- A 5 Year Plan1R50CA278773-01A1 · under PAR-21-306 | O'SULLIVAN, CIARA C | MAYO CLINIC ROCHESTER, MN | $177,254 | ZCA1 |
| 2024 | Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials1R50CA285494-01 · under PAR-21-306 | BANSAL, AJAY | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $172,197 | ZCA1 |
| 2024 | Pediatric acute lymphoblastic leukemia: Improving outcomes through incorporation of novel targeted therapies into treatment for relapsed and newly diagnosed disease1R50CA288324-01 · under PAR-21-306 | O'BRIEN, MAUREEN MEGAN | UNIVERSITY OF COLORADO DENVER, CO | $172,013 | ZCA1 |
| 2024 | Closing the Adolescent and Young Adult Clinical Trial Enrollment Gap with an AYA (Alert, Young Adult Navigation and Alliance) Clinical Tool1R50CA282101-01A1 · under PAR-21-306 | SYMONS, HEATHER JILL | JOHNS HOPKINS UNIVERSITY, MD | $166,984 | ZCA1 |
| 2024 | Increasing Access and Participation to Early Phase Clinical Trials to the Underrepresented Populations1R50CA290098-01 · under PAR-21-306 | BARANDA, JOAQUINA C | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $159,574 | ZCA1 |
| 2024 | Enhancing accrual and diversity across gynecologic and solid tumor trials1R50CA285360-01 · under PAR-21-306 | DUSKA, LINDA | UNIVERSITY OF VIRGINIA, VA | $135,573 | ZCA1 |
| 2024 | Gynecologic cancer care: Improving clinical trial enrollment through molecular matching with targeted therapies and improving equal access to care and research for all populations1R50CA287196-01 · under PAR-21-306 | BACKES, FLOOR J. | OHIO STATE UNIVERSITY, OH | $132,015 | ZCA1 |
| 2024 | Cultivating programmatic efforts to optimize the conduct and implementation of NCI-funded clinical trials1R50CA285499-01A1 · under PAR-21-306 | ENG, CATHY | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $130,426 | ZCA1 |
| 2024 | Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia through NCI-sponsored Clinical Trials1R50CA291823-01 · under PAR-21-306 | PARIKH, SAMEER ASHOK | MAYO CLINIC ROCHESTER, MN | $124,230 | ZCA1 |
| 2024 | Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program1R50CA288382-01 · under PAR-21-306 | DIB, ELIE G | SAINT JOSEPH MERCY HEALTH SYSTEM, MI | $113,202 | ZCA1 |
| 2024 | National and Institutional Leadership and Support of NCI-Sponsored Clinical Trial Research as a Surgical Oncologist1R50CA293523-01 · under PAR-21-306 | CHAWLA, AKHIL | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $90,538 | ZCA1 |
| 2024 | Steering the next generation of NCI-sponsored clinical trials in gastroesophageal cancers1R50CA291818-01 · under PAR-21-306 | KLEMPNER, SAMUEL J | MASSACHUSETTS GENERAL HOSPITAL, MA | $78,951 | ZCA1 |
| 2023 | Dr. Salma Jabbour’s NCI Research Specialist (Clinician Scientist) Award (R50)1R50CA275877-01 · under PAR-21-306 | JABBOUR, SALMA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $196,184 | ZCA1 |
| 2023 | Increasing access to cancer trials in Minnesota (InACT-MN)1R50CA278811-01 · under PAR-21-306 | ERICKSON, BRITT KRISTINA | UNIVERSITY OF MINNESOTA, MN | $182,836 | ZCA1 |
| 2023 | Clinical Trials Specialist in Developmental Therapeutics1R50CA278916-01 · under PAR-21-306 | HIJIYA, NOBUKO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $175,944 | ZCA1 |
| 2023 | Pediatric brain tumors: Improving survival through integration of clinical molecular diagnostics and biologically targeted therapies into clinical trials1R50CA275857-01 · under PAR-21-306 | LEARY, SARAH ELISABETH SHERR | SEATTLE CHILDREN'S HOSPITAL, WA | $175,338 | ZCA1 |
| 2023 | NCI Clinical Trial Research Strategy, Harnessing of Equity, and Implementation1R50CA282102-01 · under PAR-21-306 | MAYADEV, JYOTI | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $173,920 | ZCA1 |
| 2023 | Interventional oncology clinical research specialist1R50CA276008-01 · under PAR-21-306 | SOULEN, MICHAEL C | UNIVERSITY OF PENNSYLVANIA, PA | $173,119 | ZCA1 |
| 2023 | Dr. Kim R50 Research Specialist Clinician 20221R50CA276015-01 · under PAR-21-306 | KIM, MICHELLE MIRAN | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $171,684 | ZCA1 |
| 2023 | Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint1R50CA278859-01 · under PAR-21-306 | WAGNER-JOHNSTON, NINA DELANEY | JOHNS HOPKINS UNIVERSITY, MD | $160,532 | ZCA1 |
| 2023 | Increasing Participation in NCI-Funded Clinical Trials at Winship Cancer Institute1R50CA276010-01A1 · under PAR-21-306 | COHEN, JONATHON B. | EMORY UNIVERSITY, GA | $156,603 | ZCA1 |
| 2023 | Development, review, and conduct of Children's Oncology Group (COG) Clinical Trials1R50CA275931-01 · under PAR-21-306 | DOME, JEFFREY S | CHILDREN'S RESEARCH INSTITUTE, DC | $142,360 | ZCA1 |
| 2023 | NCI Research Specialist (Clinician Scientist) Award1R50CA275928-01 · under PAR-21-306 | FOSTER, JENNIFER HAUNANI | BAYLOR COLLEGE OF MEDICINE, TX | $137,163 | ZCA1 |
| 2023 | Clinician Scientist in Leukemia1R50CA275927-01 · under PAR-21-306 | UY, GEOFFREY L | WASHINGTON UNIVERSITY, MO | $132,781 | ZCA1 |
| 2023 | Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist1R50CA275932-01 · under PAR-21-306 | GAILLARD, STEPHANIE | JOHNS HOPKINS UNIVERSITY, MD | $121,863 | ZCA1 |
| 2023 | NCI-sponsored Clinical Trial Research Specialist1R50CA281930-01 · under PAR-21-306 | GEORGE, THOMAS J. | UNIVERSITY OF FLORIDA, FL | $115,272 | ZCA1 |
| 2023 | NCI Research Specialist/Clinician Scientist Award for Urologic Oncology Research1R50CA278913-01 · under PAR-21-306 | SHUCH, BRIAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $114,720 | ZCA1 |
| 2023 | Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.1R50CA282100-01 · under PAR-21-306 | MEHNERT, JANICE M. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $110,706 | ZCA1 |
| 2023 | Clinician Scientist Supporting NCI-funded Clinical Trials at the Medical College of Wisconsin Cancer Center1R50CA275856-01 · under PAR-21-306 | HAMADANI, MEHDI HUSSAIN | MEDICAL COLLEGE OF WISCONSIN, WI | $110,604 | ZCA1 |
| 2023 | NCI Research Specialist (Clinician Scientist) Award1R50CA276021-01 · under PAR-21-306 | GOODMAN, KARYN A. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $91,123 | ZCA1 |
| 2023 | NCI R50 Clinician Scientist Award1R50CA276013-01 · under PAR-21-306 | JONAS, BRIAN A. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $86,737 | ZCA1 |
| 2023 | A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute1R50CA275822-01 · under PAR-21-306 | CHUN, STEPHEN G | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $86,702 | ZCA1 |
| 2023 | Curing Through Collaboration: Utilizing Cooperative Groups in the Fight Against Chronic Lymphocytic Leukemia and B-cell Lymphomas1R50CA275929-01 · under PAR-21-306 | STEPHENS, DEBORAH | UNIVERSITY OF UTAH, UT | $83,830 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.